

长苞铁杉中木脂素类化学成分研究
English
Lignans from the Heartwood of Nothotsuga longibracteata
-
Key words:
- pinaceae
- / Nothotsuga longibracteata
- / benzyl furanone
- / lignans
-
1. Introduction
Nothotsuga longibracteata (W. C. Cheng) Hu ex C. N. Pagebelongs to Nothotsuga of Pinaceae, one of Chinese rare gymnosperms endemic plant. Nothotsuga contains only one species, N. longibracteata, commonly known as the Bristlecone Hemlock, Tsuga longibracteata, Tsugo-keteleeria longibracteata. It was an archaic plant of the quaternary glacial period, and distributed mainly in Hunan, Guangdong, Guangxi, Fujian and Guizhou provinces of China.[1] Plants of this genus have long been used as a traditional herbal medicine to treat arthritis and stomach troubles.[2] Previous chemical investigation of this plant afforded lanostane triterpenoids, lignans, flavonoids, sterols, and phenolic acids.[3-4] Aiming to identify structurally interesting metabolites from Chinese endemic medical plants, [5-8] we conducted an intensive investigation into the constituents of the heartwood of N. longibracteata. In this study, we report the isolation and structure elucidation of a rare benzyl furanone derivate, 3-(4'-hydroxy-3'-methoxy- benzyl)-2(5H)-furanone (1), and two new lignans 2~3, together with nineteen known lignans compounds 4~22 (Figure 1). The structures of these new compounds were elucidated by spectroscopic evidences including HR-ESI- MS, 1D, 2D NMR, and CD spectroscopies. The cytotoxic effects of the isolated new compounds on three human tumour cell lines (A172, SHSY5Y, and Hela) were evaluated by the MTT assay. But their showed no cytotoxic activities at the concentration of 50 μmol/L. Gastrointestinal motility of zebrafish test showed that compound 3 has the function of promoting gastrointestinal motility of zebrafish to excrete Nile red at doses 8 and 24 μmol/L by means of acting on the cholinergic nervous system. We herein present the purification, structural elucidation, and biological evaluation of these isolated and identified lignans compounds.
Figure 1
2. Results and discussion
2.1 Structure identification of compound 1
Compound 1 was obtained as a brown gum. With the molecular formula, C12H12O4, which indicated 7 degrees of unsaturation, was established from the ion of protonated molecule peak at m/z 221.0809 [M+H]+ (calcd for C12H13O4+: 221.0808) in the HR-ESI-MS. The IR spectrum of compound 1 indicated the presence of hydroxyl and carbonyl groups at 3426 and 1746 cm-1. 1H NMR, 13C NMR and heteronuclear single quantum correlation (HSQC) spectra (Table 1) of compound 1 showed the presence of a 1, 3, 4-trisubstituted benzyl unit at δH 6.72 (dd, J=8.0, 1.8 Hz, 1H), 6.76 (d, J=1.8 Hz, 1H), 6.86 (d, J=8.0 Hz, 1H), 3.52 (br. s, 2H), and δC 129.4, 111.7, 146.8, 144.7, 114.7, 121.7, 31.7; a methylene group at δH 3.52 (2H, brs) and δC 31.7; an oxygenated methylene group at δH 4.75 (m, 2H) and δC 70.5; an olefinic bond at δH 6.95 (m, 1H) and δC 134.8, 145.6; a methoxyl group at δH 3.87 (3H, s) and δC 56.1; a carbonyl group at δC 174.2 and a hydroxyl group at δH 5.58. These NMR data above indicated that compound 1 might be a benzylbutyrolactone derivative.[9] The heteronuclear multiple-bond correlations (HMBC) (Figure 2) of OCH3 (δH 3.87) with C-3' (δC 146.8), 4'-OH (δH 5.58) with C-3', C-4' and C-5', and H-6' with C-4' (δC 146.8), indicated that the methoxyl group located at C-3' and hydroxyl group located at C-4'. The HMBC correlations of H-7' with C-1', C-2' and C-6', H-6' with C-7', and H-2' with C-7' confirmed the presence of a benzyl moiety in the molecule. The HMBC correlations of H-4 with C-2 and C-5, H-5 with C-2, C-3 and C-4 established the presence of a furanone ring. Further, the connection of the benzyl moiety and the furanone ring by C-3 and C-7', was established based on the HMBC correlations of H-7' with C-2, C-3 and C-4, and H-4 with C-7'. Therefore, the structure of compound 1 was established as 3-(4'-hydroxy-3'- methoxy-benzyl)-2(5H)-furanone.
Table 1
Position 1 (CDCl3) 2 (CD3OD) δH (J in Hz) δC δH (J in Hz) δC 1 133.3 2 174.2 6.62 (br. s, 1H) 113.3 3 134.8 148.9 4 6.94~6.96 (m, 1H) 145.6 145.7 5 4.74~4.76 (m, 2H) 70.5 6.69 (overlapped, 1H) 115.9 6 6.54 (overlapped, 1H) 122.8 7 2.54~2.68 (m, 2H) 35.9 8 2.12~2.21 (m, 1H) 40.5 9 4.24 (dd, 11.1, 5.9, 1H); 4.01 (dd, 11.1, 6.5, 1H) 66.2 1' 129.4 133.8 2' 6.76 (d, 1.8, 1H) 111.7 6.56 (overlapped, 1H) 113.5 3' 146.8 149.0 4' 144.7 145.8 5' 6.86 (d, 8.0, 1H) 114.7 6.59 (overlapped, 1H) 116.0 6' 6.72 (dd, 8.1, 1.8, 1H) 121.7 6.54 (overlapped, 1H) 122.8 7' 3.52 (br. s, 2H) 31.7 2.54~2.68 (m, 2H), 35.6 8' 1.89~1.98 (m, 1H) 44.4 9' 3.68 (dd, 10.8, 6.0, 1H); 4.01 (dd, 10.8, 6.5, 1H) 62.8 1'' 173.1 2'' 2.05 (s, 3H) 21.1 3-OCH3 3.76 (s, 3H) 56.3 3'-OCH3 3.87 (s, 1H) 56.1 3.77 (s, 3H) 56.3 4'-OH 5.58 (s, 1H) Figure 2
2.2 Structure identification of compound 2
Compound 2 was isolated as a brown gum, with the molecular formula of C22H28O7 on the basis of HR-ESI-MS (m/z 427.1714 [M+Na]+, calcd for C22H28O7Na 427.1733, ), which indicated 9 degrees of unsaturation. The IR spectrum of compound 2 indicated the presence of carbonyl group at 1767 cm-1. The 1H NMR, 13C NMR and HSQC spectra (Table 1) of compound 2 displayed two 1, 3, 4-trisubstituted benzyl units at δC 133.3, 113.3, 148.9, 145.7, 115.9, 122.8, and δC 133.8, 113.5, 149.0, 145.8, 116.0, 122.8; two aryl methoxyl groups at δH 3.76 (3H) and 3.77 (3H); an acetoxy group at δC 173.1 and 21.1; four methylene groups at δC 66.2, 62.8, 35.9, 35.6; two methine groups at δC 44.4, 40.5. These structural moieties would constitute an 8, 8'-lignane skeleton for compound 2, similar to that of secoisolariciresinol[10] except for the substitution in the C-9. The structure of compound 2 was further supported by HMBC spectra (Figure 2). The HMBC correlations of H-9/C-1'', H-2''/C-1'' revealed the acetoxy group attached to C-9. The HMBC correlations of 3-OCH3/C-3, H-5/C-1, H-5/C-3, 3'-OCH3/C-3', H-5'/C-1', H-5'/C-3', showed the two methoxyl groups located at C-3 and C-3', respectively. The (8S, 8'S)-absolute stereochemistry was confirmed by the specific optical rotation and circular dichroic (CD) curve (positive Cotton effects at 228 and 291 nm) as those of 5-demethoxyniranthin.[11] Therefore, the structure of compound 2 was established to be (8S, 8'S)- 3, 3'-dimethoxyligna-4, 4', 9, 9'-tetraol-9-actate. The plane structure of compound 2 was identified already from MS in the literature, [12] but the NMR data were no reported.
2.3 Structure identification of compound 3
Compound 3 was isolated as a yellow gum. Its molecular formula, C24H30O7, which indicated 10 degrees of unsaturation, was established from the quasi-molecular ion peak at m/z 453.1880 [M+Na]+ (calcd for C24H30O7Na 453.1889) in the HR-ESI-MS. The IR spectrum of compound 3 indicated the presence of carbonyl group at 1759 cm-1. The 1H NMR spectrum (Table 2) of compound 3 displayed two methoxyl signals at δH 3.79 (s, 3H) and 3.83 (s, 3H), an AMX aromatic system at δH 6.58 (d, J=1.9 Hz, 1H), 6.64 (dd, J=8.0, 1.9 Hz, 1H), 6.81 (d, J=8.0 Hz, 1H), two aromatic protons at δH 6.29 (s, 1H) and 6.54 (s, 1H). The 13C NMR and HSQC spectra indicated a carbonyl at δC 175.8, 12 aromatic carbons at δC 110.1, 111.7, 114.5, 115.8, 122.6, 126.0, 131.6, 132.4, 144.0, 145.2 and 145.5, 146.9, two downfield methylene groups at δC 62.4 and 65.0, two methoxyl groups at δC 56.1 and 56.1, three methine carbons at δC 43.2, 46.7 and 46.9, three upfield methylene carbons at δC 19.3, 30.8 and 32.7, and a methyl carbon at δC 13.9. These NMR data suggested that compound 3 might be an aryltetrahydronaphthalene-type lignin.[13-14] 1H-1H correlated spectroscopy (COSY) (Figure 2) showed the presence of OCH2CH2CH2CH3 moiety. The HMBC correlations (Figure 2) from H-1'' to C-9 (δC 175.8), H-7 to C-9, established the location of OCH2CH2CH2CH3 moiety at C-9. The HMBC correlations from H-9' to C-7', C-8 and C-8' showed an OH attached to C-9'. The HMBC correlations from OCH3-3' to C-3', H-5' to C-3', H-5' to C-1', confirmed the presence of OCH3 at C-3'. Similarly, a methoxy group at C-5 was also assigned. The stereochemistry of different substituent groups on the tetrahydronaphthalene ring was designated using a nuclear overhauser enhancement spectroscopy (NOESY) experiment. The cross-peaks of H-7'/H-9', H-7'/H-8 and H-8/H-9' indicated that H-7', H-9' and H-8 were cofacial. The assignments were also buttressed by vicinal coupling constant value of H-7' and H-8' (J=10.7 Hz) when the dihedral angle of H-7'-H-8' took value close to 180°. The absolute stereochemistry of (7'R, 8S, 8'S)-3 was established by the circular dichroism (CD) spectrum. The positive Cotton effects at 205, 228, 293 nm and the negative Cotton effects at 227, 239, 277 nm were very similar to urinatetralin, [11] and it was further confirmed by TD-DFT ECD calculations (Figure 3). In summary, compound 3 was determined to be (7'R, 8S, 8'S)- 3', 5-dimethoxy-2, 7'-cycloligna-4, 4', 9'-triol-9-acid butyl ester.
Table 2
Position δH (J in Hz) δC Position δH (J in Hz) δC 1 126.0 4' 144.5 2 132.4 5' 6.81 (d, 8.0, 1H) 114.5 3 6.29 (s, 1H) 115.8 6' 6.64 (dd, 8.0, 1.9, 1H) 122.6 4 144.0 7' 3.91 (d, 10.7, 1H) 46.7 5 145.2 8' 2.65, 2.92 (overlapped, 1H) 43.2 6 6.54 (s, 1H) 110.1 9' 3.56 (dd, 11.8, 3.0, 1H) 3.43 (dd, 11.8, 3.5, 1H) 62.7 7 3.21 (dd, 15.7, 11.5, 1H); 2.86~2.93 (overlapped, 1H) 32.7 1'' 4.09~4.15 (m, 2H) 65.0 8 2.08~2.17 (m, 1H) 46.9 2'' 1.59~1.65 (m, 2H 30.8 9 175.8 3'' 1.33~1.42 (m, 2H 19.3 1' 136.6 4'' 0.92 (t, 7.4, 3H) 13.9 2' 6.58 (d, 1.9, 1H) 111.7 5-OCH3 3.83 (s, 3H) 56.1 3' 146.9 3'-OCH3 3.79 (s, 3H) 56.1 Figure 3
The known compounds were identified as matairesinol (4), [15] nortrachelogenin (5), [16] allo-7'-methoxymatairesi- nol (6), [17] 7R-ethoxymatairesinol (7), [18] 7'R-hydroxyma- tairesinol (8), [19] 7'S-hydroxymatairesinol (9), [19] tsugacetal (10), [20] 1-ethoxy-4-(4'-hydroxy-3'-methoxy-phenyl)-7-me- thoxy-1, 3, 3a, 4, 9, 9a-hexahydronaphtho[2, 3-c]furan-6-ol (11), [21] α-conidendrin (12), [22] 8-hydroxy-α-conidendrin (13), [23] 4, 4'-dihydroxy-3, 3'-dimethoxy-7-one-lignan-9, 9'- olid (14), [24] 8-hydroxyoxomatairesinol (15), [25] 8-hydroxy- α-conidendric acid methyl ester (16), [23] epinortrachelogenin (17), [26] isolariciresinol (18), [27] burselignan (19), [27] 3-(2, 4-dihydroxy-3-methoxybenzyl)-4-(4-hydroxy-3-meth-oxybenzy1)tetrahydrofuran (20), [28] cedrusin (21), [29] and 7'-hydroxyisolappaol A (22).[30]
All these new compounds were evaluated for their cytotoxicity against A172, SHSY5Y and Hela cells using MTT method. But these compounds are inactive (IC50 > 50 μmol/L) for all cell lines. Compounds 1~3 were evaluated for their activity of promoting gastrointestinal motility of zebrafish treated with Nile red. Compound 3 significantly promoted the Nile red excretion at doses > 8 and > 24 μmol/L. Compound 3 promoted the gastrointestinal motility weaken, at 50 and 5 μmol/L atropine, compared with the test result no atropine at 50 μmol/L. These results showed that compound 3 might promote the gastrointestinal motility of zebrafish via acted on the cholinergic nervous system (Figure 4).
Figure 4
3. Conclusions
The phytochemical investigation of N. longibracteata gave a new benzyl furanone derivate (1), two new lignans 2~3 and 19 known lignans compounds 4~22. Compound 1 was a novel furanone derivate, and it was first isolated from plants as natural product skeleton as well as we know.[9] Compound 1 maybe the degradation of benzyl product of dibenzylbutyrolactone lignan. Compound 3 has the function of promoting gastrointestinal motility of zeb- rafish to excrete Nile red at doses 8 and 24 μmol/L by means of acting on the cholinergic nervous system.
4. Experimental
4.1 Instruments and reagents
UV spectra were recorded on a Perkin-Elmer Lambda 35 UV-Vis spectrophotometer. CD spectra were recorded on a Chirascan circular dichroism spectrometer (Applied Photophysics Ltd, Leatherhead, U.K.). HR-ESI-MS spectra were measured on a Bruker MicrO TOF-Q II mass spectrometer. Optical rotations were determined on a Perkin-Elmer-241 polarimeter (Perkin Elmer, Inc., Waltham, MA, USA). IR spectra were measured on a PerkinElmer one FT-IR spectrometer (KBr). 1D NMR and 2D NMR spectra were recorded on a Bruker-AVANCE III-400 or an Agilent DD2400-MR instrument using TMS as the internal reference. Column chromatography was performed using silica gel (300~400 mesh, Qingdao marine Chemical Ltd., Qingdao, P. R. China). Semi-preparative high-pressure liquid chromatography (HPLC) was performed on a LC 3000 system (Beijing ChuangXingTongHeng Science and Technology Co., Ltd.) equipped with ODS column (5 μm, i.d. 10 mm×250 mm, YMC and H & E).
4.2 Plant materials
The heartwood of this plant was collected from Huang Sang Nature Reserve in Hunan province, China, in August 2016, and identified as Nothotsuga longibrteata (W. C. Cheng) Hu ex C. N. Page by Prof. Fa-Ming Wu (Zunyi Medical University). A voucher specimen (ZMC No. 20160814) was deposited at School of Pharmacy of Zunyi Medical University.
4.3 Extraction and separation
The air-dried and finely ground heartwood of N. longibracteata (5.0 kg) was extracted with 95% ethanol (25 L) for three times at room temperature (5 d each). The ethanol portion was evaporated under reduced pressure to get a crude extract (900 g), which was further suspended in warm distilled water (2.0 L) and extracted successively with petroleum ether, EtOAc, and n-BuOH (repeat each solvent 3 times), respectively. The EtOAc extract (205 g) was subjected to silica gel column chromatography (80 mm×600 mm, 400 g, 300~400 mesh), eluted with a gradient of petroleum ether-EtOAc (V:V=10:1→1:2) to afford 6 fractions (Fr.1~Fr.6).
Fr.4 was further separated by silica gel column chromatography to get 3 fractions (Fr.4.1~Fr.4.3). Fr.4.1 was purified by a Sephadex LH-20 column chromatography (MeOH) and divided into 8 subfractionses (Fr.4.1.1~Fr.4.1.8). Fr.4.1.3 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=60:40) to yield compound 7 (tR 10.3 min, 10.5 mg). Fr.4.1.5 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=60:40) to get compounds 10 (tR 9.7 min, 10.9 mg) and 11 (tR 14.3 min, 14.1 mg). Fr.4.2 was purified by semi-preparative HPLC with MeOH-H2O (V:V=50:50) to yield 6 subfractionses (Fr.4.2.1~Fr.4.2.6). Fr.4.2.3 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=58:42) to obtain compound 5 (tR 8.7 min, 17.6 mg). Fr.4.2.5 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=65:35) to obtain compound 4 (tR 17.1 min, 30.6 mg). Fr.4.2.6 was repeated recrystallization to get compound 12 (20.5 mg).
Fr.5 was further separated by silica gel column chromatography to get 2 fractions (Fr.5.1~Fr.5.2). Fr.5.1 was purified by a Sephadex LH-20 column chromatography (MeOH) and divided into 10 subfractionses (Fr.5.1.1~Fr.5.1.10). Fr.5.1.2 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=60:40) to yield compounds 16 (tR 10.3 min, 10.5 mg) and 6 (tR 18.3 min, 10.5 mg). Fr.5.1.3 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=55:45) to get compound 1 (tR 9.7 min, 10.9 mg). Fr.5.1.6 was purified by semi- preparative HPLC with MeOH-H2O (V:V=40:60) to obtain compound 13 (tR 24.3 min, 20.3 mg). Fr.5.2 was separated by semi-preparative HPLC with MeOH-H2O (V:V=23:77→62:38) to yield 7 subfractionses (Fr.5.2.1~Fr.5.2.7). Fr.5.2.2 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=33:67) to obtain compounds 9 (tR 27.1 min, 16.5 mg) and 8 (tR 30.0 min, 14.9 mg). Fr.5.2.3 was further purified by semi-pre- parative HPLC with MeOH-H2O (V:V=42:58) to obtain compound 14 (tR 24.1 min, 19.5 mg). Fr.5.2.4 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=45:55) to get compound 17 (tR 32.6 min, 17.5 mg). Fr.5.2.5 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=42:58) to obtain compound 15 (tR 35.4 min, 20.3 mg).
Fr.6 was further separated by silica gel column chromatography to get 5 fractions (Fr.6.1~Fr.6.5). Fr.6.2 was purified by Sephadex LH-20 column chromatography (MeOH) and divided into 8 subfractionses (Fr.6.2.1~Fr.6.2.8). Fr.6.2.4 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=23:77) to yield compound 18 (tR 18.5 min, 23.5 mg). Fr.6.2.5 was isolated by semi-preparative HPLC with MeOH-H2O (V:V=37:63→50:50) to obtain 14 subfractionses (Fr.6.2.5.1~Fr.6.2.5.14). Fr.6.2.5.3 was further purified by semi- preparative HPLC with MeOH-H2O (V:V=25:75) to get compounds 21 (tR 23.9 min, 5.4 mg) and 19 (tR 25.0 min, 3.7 mg). Fr.6.2.5.6 was purified by semi-preparative HPLC with MeOH-H2O (V:V=38:62) to obtain compound 20 (tR 42.1 min, 12.4 mg). Fr.6.2.5.8 was further purified by semi-preparative HPLC with MeOH-H2O (V:V=47:53) to yield compound 22 (tR 47.7 min, 9.1 mg). Fr.6.4 was separated by semi-preparative HPLC with MeCN-H2O (V:V=35:65) to yield 5 subfractionses (Fr.6.4.1~Fr.6.4.5). Fr.6.4.3 was further purified by semi-preparative HPLC with MeCN-H2O (V:V=35:65) to obtain compounds 2 (tR 37.1 min, 10.5 mg) and 3 (tR 45.9 min, 13.7 mg).
3-(4'-Hydroxy-3'-methoxybenzyl)-2(5H)-furanone (1): Brown gum; [α]20 D 0 (c 0.01, MeOH); UV (MeOH) λmax [log ε/(L•mol-1•cm-1)]: 282 (3.35) nm; IR (KBr) νmax: 3426, 1746, 1514, 1070, 1040, 667 cm-1; 1H NMR and 13C NMR data, Table 1; HR-ESI-MS m/z:221.0809 [M+H]+ (calcd for C12H13O4+, 221.0808).
(8S, 8'S)-3, 3'-Dimethoxyligna-4, 4', 9, 9'-tetraol-9-actate (2): Brown gum; [α]20 D+20 (c 0.01, MeOH); UV (MeOH) λmax [log ε/(L•mol-1•cm-1)]: 280 (2.52) nm; IR (KBr) νmax: 3432, 1720, 1807, 1516, 1269, 1031 cm-1; CD (c 6.00× 10-5 mol/L, MeOH) λmax [∆ε/(deg•cm2•dmol-1)] 205 (+4.28), 211 (-9.21), 228 (+2.61), 291 (+0.94) nm; 1H NMR and 13C NMR data see Table 1; HR-ESI-MS calcd for C22H28O7Na [M+Na]+ 427.1733, found 427.1714.
(7'R, 8S, 8'S)-3', 5-Dimethoxy-2, 7'-cycloligna-4, 4', 9'-triol- 9-acid butyl ester (3): Yellow gum; [α]20 D-24 (c 0.02, MeOH); UV (MeOH) λmax [log ε/(L•mol-1•cm-1)]: 285 (2.42) nm; IR (KBr) νmax: 3410, 1759, 1516, 1271, 1218, 994 cm-1; CD (c 6.00×10-5 mol/L, MeOH) λmax [∆ε/(deg•cm2•dmol-1)] 206 (+22.21), 225 (+2.02), 240 (-6.39), 274 (-4.05), 292 (+8.50) nm; 1H NMR and 13C NMR data see Table 2; HR-ESI-MScalcd for C24H30O7Na [M+Na]+ 453.1889, found 453.1880.
4.4 Cytotoxicity assay
Three human cancer cell lines, A172, SHSY5Y and Hela cells, were used in the cytotoxicity assay. The cytotoxicity assay was performed using the MTT method as literature.[31]Using cis-platin and taxol as positive control, all tests were performed in triplicate.
4.5 Gastrointestinal motility of zebrafish
Zebrafish culture and experimental procedureof gastrointestinal motility were performed as literature.[32]
4.6 Computational details
The theoretical calculation of compound 7'R, 8S, 8'S-3 was carried out as described previously using Gaussian 16.[33] Conformational analysis was performed using Conflex 8 (Boltzman Jump, Smart Minimizer using the MMFF). All configurations (relative energy < 41.9 kJ/mol) were used in optimizations at the B3LYP/6-31G(d, p) in MeOH. The theoretical calculation of ECD was performed using TD- DFT at the B3LYP/6-31G(2d, 2p) level in MeOH.[34] Spec- Dis 1.71 was used to sum up single ECD spectra after a Boltzmann statistical weighting, and for the Gauss curve generation (σ=0.2 eV) and the comparison with experimental data.
Supporting Information 1D NMR, 2D NMR, HR-ESI-MS spectra of compounds 1~3, and CD spectra of compounds 2 and 3. The Supporting Information is available free of charge via the Internet at http://sioc-journal.cn.
-
-
[1]
Qiu, Y. J.; Yi, G. M.; Ning, Z. L.; Huang, H. W. J. Plant Resour. Environ. 2011, 20, 53.
-
[2]
张惠源, 张志英, 中国中药资源志要, 科学出版社, 北京, 1994.Zhang, H. Y.; Zhang, Z. Y. The Chinese Traditional Medicine Resource Records, Science Press, Beijing, 1994 (in Chinese).
-
[3]
肖世基, 史大斌, 袁泽利, 陈永正, 张茂生, 丁立生, 周燕, 有机化学, 2016, 36, 1686. doi: 10.6023/cjoc201601035Xiao, S. J.; Shi, D. B.; Yuan, Z. L.; Chen, Y. Z.; Zhang, M. S.; Ding, L. S.; Zhou, Y. Chin. J. Org. Chem. 2016, 36, 1686 (in Chinese). doi: 10.6023/cjoc201601035
-
[4]
Liu, G. Y.; Nie, Q. F.; Weng, Q. H.; Zhang, M. S.; Ding, L. S.; Zhou, Y.; Chen, F.; Xiao, S. J. Biochem. Syst. Ecol. 2018, 77, 4. doi: 10.1016/j.bse.2017.12.004
-
[5]
Xiao, S. J.; Chen, F.; Ding, L. S.; Zhou, Y. Chin. J. Nat. Med. 2015, 13, 65.
-
[6]
Xiao, S. J.; Zhang, M. S.; Guo, D. L.; Chen, F.; Zhou, Y.; Ding, L. S. Chin. Chem. Lett. 2017, 28, 1049. doi: 10.1016/j.cclet.2016.12.011
-
[7]
Zhang, M. S.; Deng, Y.; Fu, S. B.; Guo, D. L.; Xiao, S. J. Molecules 2018, 23, 1539. doi: 10.3390/molecules23071539
-
[8]
Xiao, S. J.; Guo, D. L.; Xia, B.; Allen, S.; Gu, Y. C.; Chen, F.; Ding, L. S.; Zhou, Y. Planta Med. 2016, 82, 723. doi: 10.1055/s-0042-100915
-
[9]
Schmidt, B.; Wolf, F.; Ehlert, C. J. Org. Chem. 2016, 81, 11235. doi: 10.1021/acs.joc.6b02207
-
[10]
Sugahara, T.; Yamauchi, S.; Kondo, A.; Ohno, F.; Tominaga, S.; Nakashima, Y.; Kishida, T.; Akiyama, K.; Maruyama, M. Biosci. Biotechnol. Biochem. 2007, 71, 2962. doi: 10.1271/bbb.70358
-
[11]
Chang, C. C.; Lien, Y. C.; Liu, K. C. S. C.; Lee, S. S. Phyto- chemistry 2003, 63, 825.
-
[12]
Yamamoto, S.; Otto, A.; Simoneit, B. R. J. Mass Spectrom. 2004, 39, 1337. doi: 10.1002/jms.726
-
[13]
Li, N.; Wu, J. L.; Hasegawa, T.; Sakai, J.; Bai, L. M.; Wang, L. Y.; Kakuta, S.; Furuya, Y.; Ogura, H.; Kataoka, T.; Tomida, A.; Tsuruo, T.; Ando, M. J. Nat. Prod. 2007, 70, 544.
-
[14]
Wang, L. N.; Qin, L. L.; He, J. L.; Li, X. H.; Cao, Z. X.; Gu, Y. C.; Deng, F.; Deng, Y. J. Asian Nat. Prod. Res. 2019, 21, 999. doi: 10.1080/10286020.2018.1487957
-
[15]
Prabhu, B. R.; Mulchandani, N. B. Phytochemistry 1985, 24, 329. doi: 10.1016/S0031-9422(00)83546-3
-
[16]
Tiwari, A. K.; Srinivas, P. V.; Kumar, S. P.; Rao, J. M. J. Agric. Food Chem. 2001, 49, 4642. doi: 10.1021/jf010573a
-
[17]
Kawamura, F.; Miyachi, M.; Kawai, S.; Ohashi, H. J. Wood Sci. 1998, 44, 47. doi: 10.1007/BF00521874
-
[18]
Eklund, P. C.; Sundell, F. J.; Smeds, A. I.; Sjoholm, R. E. Org. Biomol. Chem. 2004, 2, 2229. doi: 10.1039/B402849J
-
[19]
Fischer, J.; Reynolds, A. J.; Sharp, L. A.; Sherburn, M. S. Org. Lett. 2004, 6, 1345. doi: 10.1021/ol049878b
-
[20]
Fang, J.; Wei, K.; Cheng, Y.; Cheng, M.; Wang, Y. Phytochemistry 1985, 24, 1363. doi: 10.1016/S0031-9422(00)81134-6
-
[21]
Cambie, R. C.; Clark, G. R.; Craw, P. A.; Jones, T. C.; Rutledge, P. S.; Woodgate, P. D. Aust. J. Chem. 1985, 38, 1631. doi: 10.1071/CH9851631
-
[22]
赵友兴, 李承森, 罗晓东, 刘玉清, 周俊, 云南植物研究, 2004, 26, 229.Zhao, Y. X.; Luo, X. D.; Zhou, J. Acta Bot. Yunnanica 2004, 26, 229 (in Chinese).
-
[23]
Kawamura, F.; Kawai, S.; Ohashi, H. Phytochemistry 1997, 44, 1351. doi: 10.1016/S0031-9422(96)00705-4
-
[24]
赵友兴, 李承森, 罗晓东, 刘玉清, 周俊, 云南植物研究, 2005, 27, 217. doi: 10.3969/j.issn.2095-0845.2005.02.013Zao, Y. X.; Li, C. S.; Luo, X. D.; Liu, Y. Q.; Zhou, J. Acta Bot. Yunnanica 2005, 27, 217 (in Chinese). doi: 10.3969/j.issn.2095-0845.2005.02.013
-
[25]
Kawamura, F.; Kawai, S.; Ohashi, H. Phytochemistry 2000, 54, 439. doi: 10.1016/S0031-9422(00)00126-6
-
[26]
Yamauchi, S.; Sugahara, T.; Nakashima, Y.; Okada, A.; Akiyama, K.; Kishida, T.; Maruyama, M.; Masuda, T. Biosci. Biotechnol. Biochem. 2006, 70, 1934. doi: 10.1271/bbb.60096
-
[27]
Jutiviboonsuk, A.; Zhang, H.; Tan, G. T.; Ma, C.; Van Hung, N.; Manh Cuong, N.; Bunyapraphatsara, N.; Soejarto, D. D.; Fong, H. H. Phytochemistry 2005, 66, 2745. doi: 10.1016/j.phytochem.2005.09.025
-
[28]
Estévez-Braun, A.; Estévez-Reyes, R.; González-Pérez, J. A.; González, A. G. J. Nat. Prod. 1995, 58, 887. doi: 10.1021/np50120a010
-
[29]
毕跃峰, 郑晓珂, 刘宏民, 冯卫生, 冀春茹, 张勇忠, 药学学报, 2001, 33, 832. doi: 10.3321/j.issn:0513-4870.2001.11.007Bi, Y. F.; Zhen, X. K.; Liu, H. M.; Feng, W. S.; Ji, C. R.; Zhang, Y. Z. Acta Pharm. Sin. 2001, 33, 832 (in Chinese). doi: 10.3321/j.issn:0513-4870.2001.11.007
-
[30]
Yang, M.; Wang, C. M.; Zhang, Q.; Han, Y. F.; Jia, Z. J. Pharmazie 2004, 59, 972.
-
[31]
Lu, C. Y.; Li, H. X.; Li, S.; Qiu, L.; Yu, S.; Cao, Z. X.; Guo, D. L.; Deng, Y. Nat. Prod. Commun. 2017, 12, 1463.
-
[32]
He, X.; Yang, J.; Qiu, L.; Feng, D.; Ju, F.; Tan, L.; Li, Y. Z.; Gu, Y. C.; Zhang, Z.; Guo, D. L.; Deng, Y. Molecules 2019, 24, 299. doi: 10.3390/molecules24020299
-
[33]
Li, S.; Chen, J. F.; Qin, L. L.; Li, X. H.; Cao, Z. X.; Gu, Y. C.; Guo, D. L.; Deng, Y. J. Asian Nat. Prod. Res. 2020, 22, 138. doi: 10.1080/10286020.2018.1540606
-
[34]
Li, X. H.; Hu, H. W.; Tan, L.; Wu, W. L.; Cao, Z. X.; Gu, Y. C.; Deng, Y.; Guo, D. L. Nat. Prod. Commun. 2018, 13, 1419.
-
[1]
-
Table 1. 1H NMR and 13C NMR spectral data of compounds 1 and 2 (400/100 MHz)
Position 1 (CDCl3) 2 (CD3OD) δH (J in Hz) δC δH (J in Hz) δC 1 133.3 2 174.2 6.62 (br. s, 1H) 113.3 3 134.8 148.9 4 6.94~6.96 (m, 1H) 145.6 145.7 5 4.74~4.76 (m, 2H) 70.5 6.69 (overlapped, 1H) 115.9 6 6.54 (overlapped, 1H) 122.8 7 2.54~2.68 (m, 2H) 35.9 8 2.12~2.21 (m, 1H) 40.5 9 4.24 (dd, 11.1, 5.9, 1H); 4.01 (dd, 11.1, 6.5, 1H) 66.2 1' 129.4 133.8 2' 6.76 (d, 1.8, 1H) 111.7 6.56 (overlapped, 1H) 113.5 3' 146.8 149.0 4' 144.7 145.8 5' 6.86 (d, 8.0, 1H) 114.7 6.59 (overlapped, 1H) 116.0 6' 6.72 (dd, 8.1, 1.8, 1H) 121.7 6.54 (overlapped, 1H) 122.8 7' 3.52 (br. s, 2H) 31.7 2.54~2.68 (m, 2H), 35.6 8' 1.89~1.98 (m, 1H) 44.4 9' 3.68 (dd, 10.8, 6.0, 1H); 4.01 (dd, 10.8, 6.5, 1H) 62.8 1'' 173.1 2'' 2.05 (s, 3H) 21.1 3-OCH3 3.76 (s, 3H) 56.3 3'-OCH3 3.87 (s, 1H) 56.1 3.77 (s, 3H) 56.3 4'-OH 5.58 (s, 1H) Table 2. 1H NMR and 13C NMR spectral data of compound 3 (400/100 MHz, in CDCl3)
Position δH (J in Hz) δC Position δH (J in Hz) δC 1 126.0 4' 144.5 2 132.4 5' 6.81 (d, 8.0, 1H) 114.5 3 6.29 (s, 1H) 115.8 6' 6.64 (dd, 8.0, 1.9, 1H) 122.6 4 144.0 7' 3.91 (d, 10.7, 1H) 46.7 5 145.2 8' 2.65, 2.92 (overlapped, 1H) 43.2 6 6.54 (s, 1H) 110.1 9' 3.56 (dd, 11.8, 3.0, 1H) 3.43 (dd, 11.8, 3.5, 1H) 62.7 7 3.21 (dd, 15.7, 11.5, 1H); 2.86~2.93 (overlapped, 1H) 32.7 1'' 4.09~4.15 (m, 2H) 65.0 8 2.08~2.17 (m, 1H) 46.9 2'' 1.59~1.65 (m, 2H 30.8 9 175.8 3'' 1.33~1.42 (m, 2H 19.3 1' 136.6 4'' 0.92 (t, 7.4, 3H) 13.9 2' 6.58 (d, 1.9, 1H) 111.7 5-OCH3 3.83 (s, 3H) 56.1 3' 146.9 3'-OCH3 3.79 (s, 3H) 56.1 -

计量
- PDF下载量: 3
- 文章访问数: 1266
- HTML全文浏览量: 243